Simponi Fungal Infection Warning Issued by FDA

AboutLawsuits

Add Your Comments

The FDA issued a MedWatch Alert on Thursday to remind doctors about the potential side effects of Simponi, a recently-approved drug for treatment of arthritis, which can increase the risk of serious fungal infections. Delays in recognizing the infections and starting patients on antifungal treatments could result in potentially life-threatening injuries.

Simponi (golimumab), which is manufactured by Centocor Ortho Biotech, Inc., is a type of medication known as a TNF-blocker. The class of medications, which also includes Enbrel (etanercept), Humira (adalimumab), Remicade (infliximab) and Cimzia (certolizumab pegol), have been associated with an increased risk of hitoplasmosis and other invasive fungal infections.

The FDA approved Simponi last month for the treatment of psoriatic arthritis and ankylosing spondylitis, and a “black box” warning was placed on the drug at that time about the potential side effects, which is the strongest warning that can be placed on a prescription medication.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

In September 2008, the FDA required that a “black box” warning be placed on all Tumor Necrosis Factor-alpha blocking drugs (TNF-blockers) after discovering that many doctors were failing to consistently recognize invasive fungal infections in patients treated with the drugs. Although information about the infection side effects was already contained elsewhere in the drugs warnings, they were not prominently displayed on the label.

In addition to histoplasmosis, other opportunistic fungal infections associated with TNF-blockers include coccidioidomycosis, blastomycosis, candidiasis, aspergilosis and pneumocystosi.

Doctors have been urged to watch for signs of potential Simponi side effects, which could resemble the flu. Symptoms could include coughing, fatigue, weight loss, sweating and shortness of breath.

Over the past decade, the FDA has reported 241 cases of histoplasmosis connected to the use of TNF-blockers, with 45 of those cases resulting in death. In at least 21 cases, doctors did not recognize the fungal infection in time and delayed antifungal treatment, which led to 12 of those deaths. The cases have occurred primarily in the Mississippi River Valley and the Ohio River Valley, where the fungus is prevalent.

Tags: Cimzia, Enbrel, Humira, Infection, Remicade, Simponi

More Lawsuit Stories

6 Comments

Gretchen
My husband received his first infusion of Simponi Aria March 2024. Two weeks later he broke out in an itchy rash from head to toe. We fought it for several months. Finally told to see a dermatologist. She prescribed a strong antibiotic 500 mg four times daily but did not suspend his blood thinner. He collapsed, spent twenty-eight days in hospital, twenty units of blood, four units of plasma. Was told he was dying but survived to spend two months in rehab. This medication is a black box medication and can be very dangerous.
Kevin
I have been injecting Simponi for approximately 7 years with the only side effects being a mild case of oral thrush and a sensitivity to sunburn. This is the third TNF type treatment I have used for my ankylosis spondylitis and without Simponi my life would be very limited. The first TNF drug caused headaches and a severe rash. The second one didn’t work. I was also on methotrexate which caused my skin to scale so I stopped taking it.
John
My wife received her second infusion of simponi aria end of October 2018. Four weeks later she experienced a SEVERE outbreak of psoriasis on her legs, head, and many other parts of her body.
George
Few months ago my wife was administered the simponi infusion. Today. She’s laying in the ICU fighting for her life. Doctors doubt she will make it. Simponi has been identified as the major contributor to her rapidly deteriorating condition!
carol
I took simponi by injection for only 2 months and 5 years later I am still suffering. I got pustular psoriasis from simponi. I still have side effects from simponi. I wish I never sought help for my arthritis. As my life continues to spiral from this horrible drug.
Bruce
After 6 months of taking simponi i developed flue like symptoms ,rash ,sebere chills ,fever ,red/purple swollen eye ,severe skin and body pain,severe headachs .resulting in a hospital stay.they could not identify why .only after a biopsy did it show hypersencitivy .now massive doses of steroids seem to be the treatment .I lost some of my vision and still in pain ,severe fatigue ,and dizziness . I just about can take care of myself.

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026
The JPML will hear oral arguments in late September over whether to consolidate all federal Abbott Laboratories and Nevro spinal cord stimulator lawsuits for coordinated pretrial proceedings.
Lawsuit Alleges DraftKings Predictions 'Event Contracts' Are Unlicensed Sports Betting
A California man has filed a class action lawsuit alleging DraftKings offers sports betting through its Predictions platform in states where it lacks sportsbook authorization.
Abbott-Similac-NEC-Settlement
Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.